Hermes Biosciences
2 known investors
Hermes Biosciences develops a benchtop extracellular vesicle isolation system that purifies exosomes from bodily fluids and cell culture media for research and clinical applications in oncology, degenerative disease, and regenerative medicine.
Investors · 2
Frequently asked questions
- What does Hermes Biosciences do?
- Hermes Biosciences develops a benchtop extracellular vesicle isolation system that purifies exosomes from bodily fluids and cell culture media for research and clinical applications in oncology, degenerative disease, and regenerative medicine.
- Who are Hermes Biosciences's investors?
- Hermes Biosciences's investors include GENERAL INCEPTION, Paladin Capital Group.